(Q45737041)

15 December 2017

0 references

1 reference

title

Chemoprevention of hepatocellular carcinoma in hepatitis C virus-related cirrhosis: first, eliminate the virus (English)

1 reference

15 December 2017

0 references

1 reference

1

1 reference

15 December 2017

Degos F

2

1 reference

15 December 2017

publication date

1 April 2001

1 reference

15 December 2017

published in

Journal of Hepatology

1 reference

15 December 2017

volume

34

1 reference

15 December 2017

issue

4

1 reference

15 December 2017

page(s)

606-609

1 reference

Main Causes of Death in Cirrhosis

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Compensated cirrhosis: Natural history and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Survival and prognostic indicators in compensated and decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Long-term prognosis and prognostic factors of liver cirrhosis in the 1980s

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Modeling the hepatitis C virus epidemic in France

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Can a vitamin prevent hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Predictive factors for postoperative recurrence of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Fibrosis in patients with chronic hepatitis C: detection and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

High malignancy of hepatocellular carcinoma in alcoholic patients with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

HCV-associated liver cancer without cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Hepatitis B immunisation in Singapore.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900043-5

7 January 2021

10.1016/S0168-8278(01)00043-5

Identifiers

DOI

1 reference

15 December 2017

1 reference